Announcements Trials
Browse Landscape

Phase

Phase 3 2

Status

Terminated 1Completed 1

Sponsor Class

OTHER 1INDUSTRY 1

Study Type

Interventional 2

Sponsor

Cancer Type

Classical hematology 2

Conditions

Neoplasms 3Venous Thrombosis 2Venous Thromboembolism 2Thrombosis 1Small Cell Lung Carcinoma 1Pulmonary Embolism 1Hemorrhage 1Carcinoma, Small Cell 1

Interventions

Dalteparin 11apixaban 9Enoxaparin 7edoxaban 5Tinzaparin 5Rivaroxaban 4Heparin, Low-Molecular-Weight 4Dabigatran 3bemiparin 2abelacimab 2Warfarin 2Nadroparin 2MAA868 2Fondaparinux 2reviparin 1myotubularin 1isoquercitrin 1certoparin 1atezolizumab 1acarboxyprothrombin 1Ultrasonography, Doppler, Duplex 1Rosuvastatin Calcium 1Phenprocoumon 1Models, Biological 1Medication Therapy Management 1Intermittent Pneumatic Compression Devices 1Imaging, Three-Dimensional 1Hospitals 1Heparin 1Fluorodeoxyglucose F18 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Interventional × Venous Thrombosis × bemiparin × Clear all
NCT01164046 2014-12-03

Longheva

University Medical Center Groningen

Phase 3 Terminated
56 enrolled
Classical hematology

Neoplasms, Venous Thrombosis, Venous Thromboembolism

NCT00219973 2010-04-28

CANBESURE STUDY (Cancer, Bemiparin and Surgery Evaluation)

Rovi Pharmaceuticals Laboratories

Phase 3 Completed
526 enrolled
Classical hematology

Hemorrhage, Neoplasms, Pulmonary Embolism, Venous Thrombosis, Venous Thromboembolism

Data powered by HemOnc (CC BY 4.0) Colophon âš¡